WEDNESDAY, Nov. 23, 2022 (HealthDay News) — Even if you’ve already had COVID-19, you can still benefit from a vaccine that can help prevent another infection, a new study shows. Danish patients gained between 60% and 94% protection against reinfection, depending on the COVID variant wave, the researchers found. TheContinue Reading

MONDAY, Nov. 21, 2022 (HealthDay News) — Vaccines have become a hot topic in the past few years, but a new survey finds many parents aren’t discussing immunization with their child’s doctor. Though a child’s pediatrician has often been the go-to resource on vaccines, the University of Michigan Medicine pollContinue Reading

FRIDAY, Nov. 18, 2022 (HealthDay News) — Pfizer’s updated COVID booster shots are proving their mettle against emerging omicron variants, the company announced Friday. The latest version of the vaccine generated virus-fighting antibodies against four more omicron lineages, including the troubling BQ.1.1 variant. Notably, the immune response wasn’t as strongContinue Reading

FRIDAY, Nov. 18, 2022 (HealthDay News) — The Biden administration on Thursday offered assistance to communities and hospitals dealing with a surge in cases of pediatric respiratory illnesses, but it did not declare a national public health emergency. The Children’s Hospital Association and the American Academy of Pediatrics had askedContinue Reading

FRIDAY, Nov. 18, 2022 (HealthDay News) — It might be tempting to buy prescription medication online, but buyers should beware, the U.S. Food and Drug Administration warns. While some pharmacy websites operate legally and can offer convenience, privacy and lower costs, others may be selling unapproved, counterfeit and unsafe medications,Continue Reading

THURSDAY, Nov. 17, 2022 (HealthDay News) — Ayahuasca, a powerful psychoactive drug derived from a South American plant, is a traditional Amazonian-based medicine and an increasingly popular hallucinogenic brew used by devotees worldwide. But what is the ayahuasca experience really like? An international survey of thousands of men and womenContinue Reading

THURSDAY, Nov. 17, 2022 (HealthDay News) — People battling heart failure should make the time to get their flu shots now, a new study suggests. Not only will the shots help prevent influenza in this high-risk group, but it could also reduce pneumonia infections and cardiac complications, researchers report. “IfContinue Reading

WEDNESDAY, Nov. 16, 2022 (HealthDay News) — Babies born via cesarean section may not mount as strong an immune response after some childhood vaccines compared to babies delivered vaginally, researchers suggest. Antibody levels can be checked in blood or saliva, and babies born vaginally had higher levels of antibodies inContinue Reading

WEDNESDAY, Nov. 16, 2022 (HealthDay News) — The U.S. Food and Drug Administration appears poised to approve certain naloxone products for over-the-counter use, a move that would help fight the nation’s opioid epidemic. Naloxone (Narcan, Evzio) can save lives when administered soon after the first signs of an overdose fromContinue Reading

WEDNESDAY, Nov. 16, 2022 (HealthDay News) — Americans aged 25 to 44 — so-called millennials — are dying at significantly higher rates from three leading killers than similarly aged people just 10 years ago, the latest government data shows. Looking at data collected between 2000 and 2020, the new reportContinue Reading

TUESDAY, Nov. 15, 2022 (HealthDay News) — Increasing numbers of young children are showing up in emergency rooms after accidentally ingesting the cough suppressant benzonatate, U.S. health officials reported Tuesday. Benzonatate is a non-narcotic cough suppressant first approved by the U.S. Food and Drug Administration in 1958 for children agesContinue Reading

MONDAY, Nov. 14, 2022 (HealthDay News) — Moderna, Inc., announced Monday that its updated booster shot triggers strong antibody responses against three Omicron subvariants. “We are pleased to see that both of our bivalent booster vaccine candidates offer superior protection against Omicron BA.4/BA.5 variants compared to our original booster, whichContinue Reading

MONDAY, Nov. 14, 2022 (HealthDay News) — The EpiPen is a known lifesaver when someone with a serious food allergy eats something they can’t tolerate. Yet the auto-injection treatment is greatly underused in the United States, according to a new survey. Just over half of at-risk adults said they hadContinue Reading